Our Therapeutic Focus
Our robust therapeutic portfolio is the result of keen insights into multiple disease states for which we’re developing potential treatments, including plasma and non-plasma solutions alike. Understanding the mechanisms of action through which our therapies impact human health has already enabled Grifols to help enhance the daily lives of millions of patients and their families.
Immunology
Novel therapies and treatment delivery.
Hepatology and Intensive Care
Exploring treatments for liver diseases and acute life-threatening medical conditions.
Pulmonology
Investigating new administration options for patients.
Hematology
Benefiting more patients with hematologic disorders.
Neurology
Developing novel approaches that go beyond current symptomatic treatments.
Infectious Diseases
Potential solutions for the world’s most prevalent viral and bacterial infections.
Further Therapeutic Opportunities
Expanding our scientific reach to improve health.
“We are taking our scientific innovation to the next level to find treatments that enable patients to live fuller, longer and more productive lives.”
Well-rounded portfolio
Our pipeline of approximately 40 priority research projects in various development stages highlights a diverse and targeted therapeutic approach.
Grifols Starts with Patients
We’ll find the best therapeutic option for patients, be it plasma or non-plasma, to treat their diseases and make their lives more productive and fulfilling